Related Experiment Video
Updated: Sep 16, 2025

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
Persistent Angina With Nonobstructive Coronary Artery Disease: Unmasking Coronary Microvascular Dysfunction
Philip Macanovic1, Kevin Cheng2, Anantharaman Ramasamy1
1Royal Brompton Hospital, Guy's and St Thomas' NHS Foundation Trust, Chelsea, London, United Kingdom.
Coronary microvascular dysfunction (CMD) can cause angina in cancer survivors. Early, systematic assessment of coronary microvascular function is crucial for identifying this under-recognized cardiotoxicity and guiding treatment.
Area of Science:
- Cardiology
- Oncology
- Medical Diagnostics
Background:
- Coronary microvascular dysfunction (CMD) is a common cause of angina in patients with unobstructed coronary arteries.
- Cancer survivors may have a higher prevalence of CMD due to oncotherapy side effects.
Observation:
- A case of refractory angina in a Hodgkin lymphoma survivor treated with radiotherapy and chemotherapy is presented.
- Advanced diagnostics, including cardiac MRI and invasive coronary physiology, identified CMD.
Findings:
- Coronary microvascular dysfunction (CMD) was identified as a likely sequela of oncotherapy.
- Mechanism-specific treatment was initiated based on diagnostic findings.
Implications:
- CMD may be an under-recognized cardiotoxicity of cancer treatments.
- Multimodal assessment of coronary microvascular function is valuable for diagnosis and stratified management.
- Further research into oncotherapy's role in CMD is warranted.
More Related Videos
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease V: Interprofessional Care
Angina III: Clinical Manifestations and Assessment
Angina V: Nursing Management
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

